Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About


December 21, 2020
December 21, 2020
4.5.6 Skin via Facebook

French beauty tech 4.5.6 Skin, dedicated to melanin-rich complexions, raises €700 and unveils first skincare line.

WHO: 4.5.6 Skin is a beauty tech start-up catering to skin phototypes IV, V, and VI, otherwise known as melanin-rich skin. The brand’s 6-step, customized, clean, biodynamic formulas are designed for the specific needs of skin with higher levels of pigmentation.

WHY: The company intends to use the funds to further invest in R&D including testing and production, and to recruit industrial production specialists as well as sales and customer care specialists.

IN THEIR OWN WORDS: 4.5.6 Skin’s co-founder and CEO Noelly Michoux said, “We wanted to create a skincare brand that was tailored to the characteristics of those with skin phototype IV, V, VI focusing on their specific skin issues. We felt there was a huge disconnect between the financial and cultural participation of this segment in the industry and the genuine attention the industry has for them. We are a brand that puts melanin skin at the front, bottom, and center of all we do, always ensuring we put the customer’s individual skincare needs first.”

When taking a closer look at what’s available, I realized that most products out there either use natural products that don’t penetrate and sit on the skin, or otherwise, claim to use natural ingredients, but usually don’t deliver on that claim beyond minor extracts. With 4.5.6 Skin, we see a huge opportunity to raise the bar for the industry as a whole, well beyond just melanin skin care specifically.”


  • 4.5.6 Skin, dedicated to melanin-rich complexions, raised €700K in seed funding. Backers included the Be Angels and French entrepreneurs including Fotolia and eFounders Thibaud Elziere, Julien Romanetto and Frédéric Montagnon and Benoit Koerperich.
  • 4.5.6 addresses the needs of around 46 million women with higher phototype levels between ages 18 and 35, in a global market estimated close to €23.8 billion.
  • The brand’s board consists of a diverse team of business experts, derm-pharmacists and dermatologists on board: R&D Director Imen Jerbi Azaiez is a Doctor in pharmacy, skin researcher, and biomimetic formulations expert; Carlos A. Charles, MD, is a Board Certified Dermatologist and melanin expert. COO Nicolas Vincent holds an MBA from the London Business School and has held commercial and business development roles at Google and Paypal.
  • The company was selected to be part of the Cosmet’up program at the LVMH Research Center.

2 Article(s) Remaining

Subscribe today for full access